£32k
−9%vs Apr 2024ActiveSC218067Private limited company
CODEX CLINICAL RESEARCH LIMITED
Significant control: Barbara Winifred Walker (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Codex Clinical Research Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CODEX CLINICAL RESEARCH LIMITED is an active private limited company (company number SC218067) incorporated on 12 April 2001. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £32k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 9% on the prior period (£35k).
Peer position · net assets
By net assets it sits in the upper half of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
02
Ownership and control
- Mrs Barbara Winifred Walker
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 April 200125 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 26 April 2027in 185 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £32k | — | — | £6,317 | — | — | 0 |
| 30 April 2024 | £35k | — | — | £13k | — | — | 0 |
Current ratio5.56Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £31,972 at 30 April 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.56
- Incorporated five or more years agoIncorporated 12 April 2001
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 185 days
- Next accounts duein 99 days
- Accounts period endNet assets £32k · micro accounts
- Accounts period endNet assets £35k · micro accounts
- Incorporated
08
Similar companies in Edinburgh
- BOTANICS BIOTECH LIMITEDMidlothian · inc. Mar 1999
- PENTLANDS MANAGEMENT SYSTEMS LIMITEDEdinburgh · inc. Sept 1997
- ONCOBIOPHARM LIMITEDEdinburgh · inc. Jul 2005
- INTELLIPOWER GROUP PLCEast Saltoun · inc. Oct 2005
- ETIVE GEOCONSULTING LIMITEDEdinburgh · inc. Apr 2007
- FIOS GENOMICS LIMITEDEdinburgh · inc. Apr 2008
All companies incorporated on 12 April 2001 · in Apr 2001.
09
Reminders for CODEX CLINICAL RESEARCH LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.